The World Health Organisation (WHO) has warned that patients are increasingly running out of effective treatment options as bacteria develop resistance to antibiotics, making common infections more difficult to treat.
The warning, issued on Wednesday, comes amid growing concerns over antimicrobial resistance (AMR), a global health threat that is undermining the effectiveness of medicines used to treat bacterial infections.
According to the WHO, common bacteria are becoming increasingly resistant to first-line antibiotics and even some medicines reserved as a last resort when other treatments fail.
The situation has deteriorated compared with 2019, raising concerns about the ability of health systems to manage infections that were previously treatable with available medicines.
The WHO’s findings released on November 16 showed that approximately one in six laboratory-confirmed bacterial infections worldwide was resistant to antibiotics in 2023.
The organisation said the growing problem could make routine medical procedures, including surgery, childbirth and cancer treatment, increasingly risky because of the possibility of infections that are difficult to treat.
It also warned that significant gaps in diagnosis, surveillance and access to appropriate treatment were leaving patients exposed to drug-resistant infections.
Although 173 countries reported having developed national action plans to tackle antimicrobial resistance, compared with 79 in 2017, only 22 per cent had both the necessary funding and full implementation of their plans.
The WHO further disclosed that only 36 per cent of countries had national reference laboratories equipped to test for selected bacterial and fungal infections and resistance.
It said inadequate diagnostic facilities could result in patients receiving antibiotics that are ineffective or unnecessary, while resistant infections could remain undetected.
The organisation called on governments to strengthen infection prevention, improve laboratory testing, expand surveillance and ensure equitable access to essential antimicrobial medicines.
WHO Director-General, Dr Tedros Adhanom Ghebreyesus, said national plans were essential to protecting the effectiveness of medicines.
However, he stressed that having plans without implementing them would not protect patients.
“Every infection prevented means fewer antimicrobials are needed, and testing ensures that patients receive the right treatment only when necessary,” he said.
The WHO identified the misuse and overuse of antibiotics as major drivers of antimicrobial resistance, alongside inadequate infection prevention and limited access to appropriate medicines and vaccines.
It urged countries to promote responsible antibiotic use and strengthen cooperation across human, animal and environmental health sectors.
The warning comes as the world marks the 2026 World Antimicrobial Resistance Awareness Week, running from November 18 to 24, under the theme, “One Health, one action: Prevent AMR now.”
The campaign seeks to raise awareness of drug resistance and encourage governments, healthcare professionals, farmers and communities to take action against its spread.